{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35061846", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "21"}], "Language": ["eng"], "ELocationID": ["e0262903", "10.1371/journal.pone.0262903"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2022"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.", "Pagination": {"StartPage": "e0262903", "MedlinePgn": "e0262903"}, "Abstract": {"AbstractText": ["Africa denotes unique facies for hepatocellular carcinoma (HCC) characterized by a conjunction of low sensitization, restricted access to diagnosis and treatment and associated with the highest incidence and mortality in the world. We investigated whether hepatitis B (HBV), C (HCV) and D (VHD) viruses were etiological agents of HCC in Africa.", "Relevant articles were searched in PubMed, Web of Science, African Index Medicus, and African Journal Online databases, as well as manual searches in relevant reviews and included articles. Analytical studies from Africa evaluating the association between HCC development and HBV, HCV, and HDV were included. Relevant studies were selected, data extracted, and the risk of bias assessed independently by at least 2 investigators. The association was estimated using odds ratios (OR) and their 95% confidence interval (95% CI) determined by a random-effects model. Sources of heterogeneity were determined by subgroup analyses.", "A total of 36 case-control studies were included. With controls having non-hepatic disease, the overall results suggested a significantly increased risk of HCC in patients with HBV (HBeAg (OR = 19.9; 95% CI = [3.7-105.2]), HBsAg (OR = 9.9; 95%) CI = [6.2-15.6]) and DNA (OR = 8.9; 95% CI = [5.9-13.4]); HCV (Anti-HCV (OR = 9.4; 95% CI = [6.3-14.0]) and RNA (OR = 16.5; 95% CI = [7.8-34.6]); HDV (Anti-VHD, (OR = 25.8; 95% CI = [5.9-112.2]); and HBV/HCV coinfections (HBV DNA/HCV RNA (OR = 22.5; 95% CI = [1.3-387.8]). With apparently healthy controls, the overall results suggested a significantly increased risk of HCC in patients with HBV (HBsAg, (OR = 8.9; 95% CI = [6.0-13.0]); HCV (Anti-HCV, (OR = 7.7; 95% CI = [5.6-10.6]); and HBV/HCV coinfections (HBsAg/Anti-HCV (OR = 7.8; 95% CI = [4.4-13.6]) Substantial heterogeneity and the absence of publication bias were recorded for these results.", "In Africa, HBV/HCV coinfections and HBV, HCV, and HDV infections are associated with an increased risk of developing HCC. The implementation of large-scale longitudinal and prospective studies including healthy participants to search for early biomarkers of the risk of progression to HCC is urgently needed."]}, "AuthorList": [{"Identifier": ["0000-0002-9496-0445"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Mbaga", "ForeName": "Donatien Serge", "Initials": "DS"}, {"Identifier": ["0000-0002-5536-080X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Kenmoe", "ForeName": "Sebastien", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Evaluation and Research Unit, National AIDS Control Committee, Yaound\u00e9, Cameroon."}], "LastName": "Kengne-Nd\u00e9", "ForeName": "Cyprien", "Initials": "C"}, {"Identifier": ["0000-0002-4057-889X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Ebogo-Belobo", "ForeName": "Jean Thierry", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Mahamat", "ForeName": "Gadji", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Mycobacteriology, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Foe-Essomba", "ForeName": "Joseph Rodrigue", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche sur les Maladies \u00c9mergentes et Re-Emergentes, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Amougou-Atsama", "ForeName": "Marie", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bacteriology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Tchatchouang", "ForeName": "Serges", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Nyebe", "ForeName": "In\u00e8s", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Feudjio", "ForeName": "Alfloditte Flore", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Kame-Ngasse", "ForeName": "Ginette Irma", "Initials": "GI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Magoudjou-Pekam", "ForeName": "Jeannette Nina", "Initials": "JN"}, {"Identifier": ["0000-0002-6263-2017"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Fokou", "ForeName": "Lorraine K M", "Initials": "LKM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche sur les Maladies \u00c9mergentes et Re-Emergentes, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Meta-Djomsi", "ForeName": "Dowbiss", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche sur les Maladies \u00c9mergentes et Re-Emergentes, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Ma\u00efdadi-Foudi", "ForeName": "Martin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Touangnou-Chamda", "ForeName": "Sabine Aimee", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Daha-Tchoffo", "ForeName": "Audrey Gaelle", "Initials": "AG"}, {"Identifier": ["0000-0002-1248-0166"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Selly-Ngaloumo", "ForeName": "Abdel Aziz", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Protestant University of Central Africa, Yaound\u00e9, Cameroon."}], "LastName": "Nayang-Mundo", "ForeName": "Rachel Audrey", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animals Biology and Physiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Y\u00e9ngu\u00e9", "ForeName": "Jacqueline F\u00e9licit\u00e9", "Initials": "JF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Taya-Fokou", "ForeName": "Jean Bosco", "Initials": "JB"}, {"Identifier": ["0000-0003-2827-628X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Kenfack-Momo", "ForeName": "Raoul", "Initials": "R"}, {"Identifier": ["0000-0001-6702-3221"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Atembeh Noura", "ForeName": "Efietngab", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Demeni Emoh", "ForeName": "Cynthia Paola", "Initials": "CP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Tazokong", "ForeName": "Herv\u00e9 Raoul", "Initials": "HR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Bowo-Ngandji", "ForeName": "Arnol", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Sake", "ForeName": "Carole St\u00e9phanie", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Science, The University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Atenguena Okobalemba", "ForeName": "Etienne", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Njiki Bikoi", "ForeName": "Jacky", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Njouom", "ForeName": "Richard", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaound\u00e9, Cameroon."}], "LastName": "Riwom Essama", "ForeName": "Sara Honorine", "Initials": "SH"}], "GrantList": [{"GrantID": "EDCTP_TMA2019PF-2705", "Acronym": "EDCTP_", "Agency": "European &#x26; Developing Countries Clinical Trials Partnership", "Country": "Netherlands"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "MeshHeadingList": [{"QualifierName": ["epidemiology"], "DescriptorName": "Africa"}, {"QualifierName": ["epidemiology", "virology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Hepatitis Viruses"}, {"QualifierName": ["epidemiology", "virology"], "DescriptorName": "Hepatitis, Viral, Human"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["epidemiology", "virology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. 144: 1941\u20131953. doi: 10.1002/ijc.31937", "ArticleIdList": ["10.1002/ijc.31937", "30350310"]}, {"Citation": "Sung H, Ferlay J, Siegel RL (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.", "ArticleIdList": ["33538338"]}, {"Citation": "Boyle P, Levin B (2008) World Cancer Report 2008."}, {"Citation": "Maucort-Boulch D, de Martel C (2018) Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. 142: 2471\u20132477.", "ArticleIdList": ["29388206"]}, {"Citation": "de Martel C, Georges D, Bray F, Ferlay J, Clifford GM (2020) Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 8: e180\u2013e190. doi: 10.1016/S2214-109X(19)30488-7", "ArticleIdList": ["10.1016/S2214-109X(19)30488-7", "31862245"]}, {"Citation": "Cho LY, Yang JJ, Ko K-P, Park B, Shin A, et al.. (2011) Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta-analysis. International Journal of Cancer 128: 176\u2013184. doi: 10.1002/ijc.25321", "ArticleIdList": ["10.1002/ijc.25321", "20232388"]}, {"Citation": "Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. International Journal of Cancer 75: 347\u2013354. doi: 10.1002/(sici)1097-0215(19980130)75:3&lt;347::aid-ijc4&gt;3.0.co;2-2", "ArticleIdList": ["10.1002/(sici)1097-0215(19980130)75:3&lt;347::aid-ijc4&gt;3.0.co;2-2", "9455792"]}, {"Citation": "Li L, Lan X (2016) Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population. Journal of Cancer Research and Therapeutics 12: 284. doi: 10.4103/0973-1482.200763", "ArticleIdList": ["10.4103/0973-1482.200763", "28230038"]}, {"Citation": "Shi J, Zhu L, Liu S, Xie W-f (2005) A meta-analysis of case\u2013control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. British Journal of Cancer 92: 607\u2013612. doi: 10.1038/sj.bjc.6602333", "ArticleIdList": ["10.1038/sj.bjc.6602333", "PMC2362087", "15685242"]}, {"Citation": "Alfaiate D, Cl\u00e9ment S, Gomes D, Goossens N, Negro F (2020) Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Journal of Hepatology 73: 533\u2013539. doi: 10.1016/j.jhep.2020.02.030", "ArticleIdList": ["10.1016/j.jhep.2020.02.030", "32151618"]}, {"Citation": "Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, et al.. (2012) Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver International: Official Journal of the International Association for the Study of the Liver 32: 231\u2013240. doi: 10.1111/j.1478-3231.2011.02481.x", "ArticleIdList": ["10.1111/j.1478-3231.2011.02481.x", "21745272"]}, {"Citation": "Bray F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, et al.. (2021) Cancer Incidence in Five Continents Volume XI."}, {"Citation": "Kew MC (2010) Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol 2: 65\u201373. doi: 10.4254/wjh.v2.i2.65", "ArticleIdList": ["10.4254/wjh.v2.i2.65", "PMC2999270", "21160975"]}, {"Citation": "Kramvis A, Kew MC (2007) Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37: S9\u2013s19. doi: 10.1111/j.1872-034X.2007.00098.x", "ArticleIdList": ["10.1111/j.1872-034X.2007.00098.x", "17627641"]}, {"Citation": "Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47 Suppl: S2\u20136. doi: 10.1097/MCG.0b013e3182872f29", "ArticleIdList": ["10.1097/MCG.0b013e3182872f29", "PMC3683119", "23632345"]}, {"Citation": "El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264\u20131273.e1261. doi: 10.1053/j.gastro.2011.12.061", "ArticleIdList": ["10.1053/j.gastro.2011.12.061", "PMC3338949", "22537432"]}, {"Citation": "An P-P, Feng L-N, Zhang X-X, Jin Q-L (2020) Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma. Medicine 99. doi: 10.1097/MD.0000000000023659", "ArticleIdList": ["10.1097/MD.0000000000023659", "PMC7738155", "33327352"]}, {"Citation": "Liu S, Zhang H, Gu C, Yin J, He Y, et al.. (2009) Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis. JNCI: Journal of the National Cancer Institute 101: 1066\u20131082. doi: 10.1093/jnci/djp180", "ArticleIdList": ["10.1093/jnci/djp180", "PMC2720989", "19574418"]}, {"Citation": "Wong GL-H, Chan HL-Y, Yiu KK-L, Lai JW-Y, Chan VK-K, et al.. (2013) Meta-analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 37: 517\u2013526. doi: 10.1111/apt.12207", "ArticleIdList": ["10.1111/apt.12207", "23305043"]}, {"Citation": "Spearman CW, Sonderup MW (2015) Health disparities in liver disease in sub-Saharan Africa. Liver International: Official Journal of the International Association for the Study of the Liver 35: 2063\u20132071. doi: 10.1111/liv.12884", "ArticleIdList": ["10.1111/liv.12884", "26053588"]}, {"Citation": "Spearman CW, Sonderup MW (2015) Health disparities in liver disease in sub-Saharan Africa. Liver Int 35: 2063\u20132071. doi: 10.1111/liv.12884", "ArticleIdList": ["10.1111/liv.12884", "26053588"]}, {"Citation": "Kew MC (2013) Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol 12: 173\u2013182.", "ArticleIdList": ["23396727"]}, {"Citation": "Bialecki ES, Di Bisceglie AM (2005) Diagnosis of hepatocellular carcinoma. HPB (Oxford) 7: 26\u201334. doi: 10.1080/13651820410024049", "ArticleIdList": ["10.1080/13651820410024049", "PMC2023919", "18333158"]}, {"Citation": "DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemporary Clinical Trials 45: 139\u2013145. doi: 10.1016/j.cct.2015.09.002", "ArticleIdList": ["10.1016/j.cct.2015.09.002", "PMC4639420", "26343745"]}, {"Citation": "Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evidence-Based Mental Health 22: 153\u2013160. doi: 10.1136/ebmental-2019-300117", "ArticleIdList": ["10.1136/ebmental-2019-300117", "31563865"]}, {"Citation": "Schwarzer G (2007) meta: An R package for meta-analysis. R News 7: 40\u201345."}, {"Citation": "Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21: 1539\u20131558. doi: 10.1002/sim.1186", "ArticleIdList": ["10.1002/sim.1186", "12111919"]}, {"Citation": "Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ: British Medical Journal 315: 629\u2013634. doi: 10.1136/bmj.315.7109.629", "ArticleIdList": ["10.1136/bmj.315.7109.629", "PMC2127453", "9310563"]}, {"Citation": "Kenmoe S, Bowo-Ngandji A, Kengne-Nde C, Ebogo-Belobo JT, Mbaga DS, Mahamat G, et al.. Association between early viral LRTI and subsequent wheezing development, a meta-analysis and sensitivity analyses for studies comparable for confounding factors. van den Hoogen B, editor. PLoS ONE. 2021;16: e0249831. doi: 10.1371/journal.pone.0249831", "ArticleIdList": ["10.1371/journal.pone.0249831", "PMC8049235", "33857215"]}, {"Citation": "Amr S, Iarocci EA, Nasr GR, Saleh D, Blancato J, et al.. (2014) Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women. BMC Cancer 14: 893. doi: 10.1186/1471-2407-14-893", "ArticleIdList": ["10.1186/1471-2407-14-893", "PMC4258798", "25432765"]}, {"Citation": "Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, et al.. (2011) First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 3: 24\u201330. doi: 10.4254/wjh.v3.i1.24", "ArticleIdList": ["10.4254/wjh.v3.i1.24", "PMC3035699", "21307984"]}, {"Citation": "Brown SE, Howard CR, Steward MW, Ajdukiewicz AB, Whittle HC (1984) Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients. Clinical and experimental immunology 55: 355\u2013359.", "ArticleIdList": ["PMC1535819", "6199140"]}, {"Citation": "Cenac A, Develoux M, Lamothe F, Soubiran G, Vetter JM, et al.. (1987) Delta superinfection in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in a Sahelian area. Study of 112 cases versus 46 controls. Trans R Soc Trop Med Hyg 81: 994\u2013997. doi: 10.1016/0035-9203(87)90375-0", "ArticleIdList": ["10.1016/0035-9203(87)90375-0", "2845609"]}, {"Citation": "Chin\u2019ombe N, Chavhunduka E, Matarira HT (2009) Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe. Infect Agent Cancer 4: 15. doi: 10.1186/1750-9378-4-15", "ArticleIdList": ["10.1186/1750-9378-4-15", "PMC2764566", "19814789"]}, {"Citation": "Coursaget P, Leboulleux D, Le Cann P, Bao O, Coll-Seck AM (1992) Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal. Trans R Soc Trop Med Hyg 86: 552\u2013553. doi: 10.1016/0035-9203(92)90107-n", "ArticleIdList": ["10.1016/0035-9203(92)90107-n", "1282278"]}, {"Citation": "Coursaget P, Maupas P, Goudeau A, Drucker J (1978) Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma. J Clin Microbiol 7: 394\u2013395. doi: 10.1128/jcm.7.4.394-395.1978", "ArticleIdList": ["10.1128/jcm.7.4.394-395.1978", "PMC274975", "211144"]}, {"Citation": "Cronberg S, Hansson BG, Thermos M, Moestrup T, Sow AM (1984) Hepatitis D (delta agent) in primary hepatocellular carcinoma and liver disease in Senegal. Liver 4: 275\u2013279. doi: 10.1111/j.1600-0676.1984.tb00937.x", "ArticleIdList": ["10.1111/j.1600-0676.1984.tb00937.x", "6090857"]}, {"Citation": "Dhifallah I, Khedhiri M, Chouikha A, Kharroubi G, Hammami W, et al.. (2020) Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia. Arch Virol 165: 33\u201342. doi: 10.1007/s00705-019-04440-5", "ArticleIdList": ["10.1007/s00705-019-04440-5", "31630275"]}, {"Citation": "Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, et al.. (2005) Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 208: 329\u2013339. doi: 10.1016/j.ijheh.2005.04.003", "ArticleIdList": ["10.1016/j.ijheh.2005.04.003", "16217918"]}, {"Citation": "Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, et al.. (2012) TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis 33: 1219\u20131224. doi: 10.1093/carcin/bgs068", "ArticleIdList": ["10.1093/carcin/bgs068", "PMC3388490", "22759751"]}, {"Citation": "Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, et al.. (2001) The role of hepatitis C in hepatocellular carcinoma\u2014A case control study among Egyptian patients. Journal of Clinical Gastroenterology 33: 123\u2013126. doi: 10.1097/00004836-200108000-00006", "ArticleIdList": ["10.1097/00004836-200108000-00006", "11468438"]}, {"Citation": "Jaquet A, Tchounga B, Tanon A, Bagny A, Ekouevi DK, et al.. (2018) Etiology of hepatocellular carcinoma in West Africa, a case-control study. Int J Cancer 143: 869\u2013877. doi: 10.1002/ijc.31393", "ArticleIdList": ["10.1002/ijc.31393", "PMC6041181", "29569722"]}, {"Citation": "Kew MC, Desmyter J, Bradburne AF, Macnab GM (1979) Hepatitis B virus infection in southern African blacks with hepatocellular cancer. J Natl Cancer Inst 62: 517\u2013520. doi: 10.1093/jnci/62.3.517", "ArticleIdList": ["10.1093/jnci/62.3.517", "84090"]}, {"Citation": "Kew MC, Houghton M, Choo QL, Kuo G (1990) Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 335: 873\u2013874. doi: 10.1016/0140-6736(90)90474-j", "ArticleIdList": ["10.1016/0140-6736(90)90474-j", "1691422"]}, {"Citation": "Kew MC, Kassianides C, Hodkinson J, Coppin A, Paterson AC (1986) Hepatocellular carcinoma in urban born blacks: frequency and relation to hepatitis B virus infection. Br Med J (Clin Res Ed) 293: 1339\u20131341. doi: 10.1136/bmj.293.6558.1339", "ArticleIdList": ["10.1136/bmj.293.6558.1339", "PMC1342053", "3024771"]}, {"Citation": "Kirk GD, Lesi OA, Mendy M, Szyma\u00f1ska K, Whittle H, et al.. (2005) 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24: 5858\u20135867. doi: 10.1038/sj.onc.1208732", "ArticleIdList": ["10.1038/sj.onc.1208732", "16007211"]}, {"Citation": "Larouz\u00e9 B, Blumberg BS, London WT, Lustbader ED, Sankal\u00e9 M, et al.. (1977) Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa. J Natl Cancer Inst 58: 1557\u20131561. doi: 10.1093/jnci/58.6.1557", "ArticleIdList": ["10.1093/jnci/58.6.1557", "68119"]}, {"Citation": "Lightfoot K, Skelton M, Kew MC, Yu MC, Kedda MA, et al.. (1997) Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? Hepatology 26: 740\u2013742. doi: 10.1002/hep.510260328", "ArticleIdList": ["10.1002/hep.510260328", "9303506"]}, {"Citation": "Mahale P, Aka P, Chen X, Pfeiffer RM, Liu P, et al.. (2019) Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia. J Viral Hepat 26: 738\u2013749. doi: 10.1111/jvh.13065", "ArticleIdList": ["10.1111/jvh.13065", "PMC6529252", "30661282"]}, {"Citation": "Mak D, Babb de Villiers C, Chasela C, Urban MI, Kramvis A (2018) Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000\u20132012. 13: e0196057. doi: 10.1371/journal.pone.0196057", "ArticleIdList": ["10.1371/journal.pone.0196057", "PMC5931658", "29718992"]}, {"Citation": "Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, et al.. (1998) Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 27: 1563\u20131566. doi: 10.1002/hep.510270614", "ArticleIdList": ["10.1002/hep.510270614", "9620327"]}, {"Citation": "Marchio A, Amougou Atsama M, B\u00e9r\u00e9 A, Komas NP, Noah Noah D, et al.. (2018) Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma. 18: 421\u2013431. doi: 10.1007/s10238-018-0502-9", "ArticleIdList": ["10.1007/s10238-018-0502-9", "29749584"]}, {"Citation": "Mboto CI, Davies-Russell A, Fielder M, Jewell AP (2005) Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C. J Hepatocell Carcinoma 2: 20. doi: 10.1186/1477-7800-2-20", "ArticleIdList": ["10.1186/1477-7800-2-20", "PMC1262750", "16202160"]}, {"Citation": "Mets T, Smitz J, Ngendahayo P, Sabbe L, Bigilimana I, et al.. (1993) Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma. Scand J Gastroenterol 28: 331\u2013334. doi: 10.3109/00365529309090251", "ArticleIdList": ["10.3109/00365529309090251", "8387695"]}, {"Citation": "Mohamed AE, Kew MC, Groeneveld HT (1992) Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 51: 537\u2013541. doi: 10.1002/ijc.2910510406", "ArticleIdList": ["10.1002/ijc.2910510406", "1318267"]}, {"Citation": "Montaser LM, Abbas OM, Saltah AM, Waked IA (2007) Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection. J Egypt Natl Canc Inst 19: 48\u201360.", "ArticleIdList": ["18839035"]}, {"Citation": "Nishioka K, Levin AG, Simons MJ (1975) Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull World Health Organ 52: 293\u2013300.", "ArticleIdList": ["PMC2366375", "1084799"]}, {"Citation": "Ola SO, Akere A, Otegbayo JA, Odaibo GN, Olaleye DO, et al.. (2012) Are patients with primary hepatocellular carcinoma infectious of hepatitis B, C and D viruses? Afr J Med Med Sci 41: 187\u2013191.", "ArticleIdList": ["23678655"]}, {"Citation": "Olubuyide IO, Aliyu B, Olalelye OA, Ola SO, Olawuyi F, et al.. (1997) Hepatitis B and C virus and hepatocellular carcinoma. Trans R Soc Trop Med Hyg 91: 38\u201341. doi: 10.1016/s0035-9203(97)90387-4", "ArticleIdList": ["10.1016/s0035-9203(97)90387-4", "9093625"]}, {"Citation": "Omer RE, Van\u2019t Veer P, Kadaru AM, Kampman E, el Khidir IM, et al.. (2001) The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. Trans R Soc Trop Med Hyg 95: 487\u2013491. doi: 10.1016/s0035-9203(01)90013-6", "ArticleIdList": ["10.1016/s0035-9203(01)90013-6", "11706655"]}, {"Citation": "Schiefelbein E, Zekri AR, Newton DW, Soliman GA, Banerjee M, et al.. (2012) Hepatitis C virus and other risk factors in hepatocellular carcinoma. Acta Virol 56: 235\u2013240. doi: 10.4149/av_2012_03_235", "ArticleIdList": ["10.4149/av_2012_03_235", "PMC4274948", "23043603"]}, {"Citation": "Skelton M, Kew MC, Yu MC, Crookes RL, Swanevelder JP, et al.. (2000) Transfusion-transmissible virus and hepatocellular carcinoma: a case-control study. J Viral Hepat 7: 230\u2013234. doi: 10.1046/j.1365-2893.2000.00223.x", "ArticleIdList": ["10.1046/j.1365-2893.2000.00223.x", "10849266"]}, {"Citation": "Soliman AS, Hung CW, Tsodikov A, Seifeldin IA, Ramadan M, et al.. (2010) Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt. Hepatol Int 4: 681\u2013690. doi: 10.1007/s12072-010-9187-1", "ArticleIdList": ["10.1007/s12072-010-9187-1", "PMC2994623", "21286338"]}, {"Citation": "Tabor E, Gerety RJ, Vogel CL, Bayley AC, Anthony PP, et al.. (1977) Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst 58: 1197\u20131200. doi: 10.1093/jnci/58.5.1197", "ArticleIdList": ["10.1093/jnci/58.5.1197", "192895"]}, {"Citation": "Tswana SA, Moyo SR (1992) The interrelationship between HBV-markers and HIV antibodies in patients with hepatocellular carcinoma. J Med Virol 37: 161\u2013164. doi: 10.1002/jmv.1890370302", "ArticleIdList": ["10.1002/jmv.1890370302", "1279108"]}, {"Citation": "Thi Vo T, Poovorawan K, Charoen P, Soonthornworasiri N, Nontprasert A, et al.. (2019) Association between Hepatitis B Surface Antigen Levels and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection: Systematic Review and Meta-Analysis. Asian Pacific journal of cancer prevention: APJCP 20: 2239\u20132246. doi: 10.31557/APJCP.2019.20.8.2239", "ArticleIdList": ["10.31557/APJCP.2019.20.8.2239", "PMC6852811", "31450890"]}, {"Citation": "Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, et al.. (2008) HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol 103: 2254\u20132262. doi: 10.1111/j.1572-0241.2008.01974.x", "ArticleIdList": ["10.1111/j.1572-0241.2008.01974.x", "PMC2566798", "18844615"]}, {"Citation": "Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, et al.. (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195: 5\u201311. doi: 10.1086/509894", "ArticleIdList": ["10.1086/509894", "17152003"]}, {"Citation": "Truong BX, Yano Y, Seo Y, Phuong TM, Tanaka Y, et al.. (2007) Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol 79: 1293\u20131304. doi: 10.1002/jmv.20934", "ArticleIdList": ["10.1002/jmv.20934", "17607788"]}, {"Citation": "Papatheodoridis GV, Dalekos GN, Yurdaydin C, Buti M, Goulis J, et al.. (2015) Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir. J Hepatol 62: 363\u2013370. doi: 10.1016/j.jhep.2014.08.045", "ArticleIdList": ["10.1016/j.jhep.2014.08.045", "25195548"]}, {"Citation": "Kim WR, Loomba R, Berg T, Aguilar Schall RE, Yee LJ, et al.. (2015) Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer 121: 3631\u20133638. doi: 10.1002/cncr.29537", "ArticleIdList": ["10.1002/cncr.29537", "26177866"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "9"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "17", "Minute": "30"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35061846", "PMC8782350", "10.1371/journal.pone.0262903", "PONE-D-21-08686"]}}], "PubmedBookArticle": []}